.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Harvard Business School
Johnson and Johnson
Accenture
Medtronic
Deloitte
Express Scripts
Fuji
Argus Health

Generated: December 14, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: osimertinib mesylate

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Astrazeneca PharmsTAGRISSOosimertinib mesylateTABLET;ORAL208065NDAAstraZeneca Pharmaceuticals LP0310-1349-3030 TABLET, FILM COATED in 1 BOTTLE (0310-1349-30)
Astrazeneca PharmsTAGRISSOosimertinib mesylateTABLET;ORAL208065NDAAstraZeneca Pharmaceuticals LP0310-1350-3030 TABLET, FILM COATED in 1 BOTTLE (0310-1350-30)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Daiichi Sankyo
Chinese Patent Office
Fish and Richardson
Covington
Cipla
Cantor Fitzgerald
Queensland Health
Citi
Baxter

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot